Dr. Alfonso J. Alanís, is Chief Medical and Development Officer of ResearchPoint Global (RPG). Prior to joining RPG, Alanís was the CEO and Chairman of the Board of Anaclim LLC, a CRO focused on the enrollment of ethnically-balanced populations into clinical trials.
Prior to working at Anaclim, Dr. Alanís was an Executive at Eli Lilly and Company where he served in different functions for 21 years, including seven years as the Chief Medical Officer and Vice President of Global Clinical Research for that company.
A U.S. citizen, Dr. Alanís was born in Mexico City where he attended Medical School, graduating Magna cum Laude from the National Autonomous University of Mexico (UNAM). He obtained his Internal Medicine, Infectious Disease and Clinical Microbiology training at the Cleveland Clinic in Cleveland, Ohio.
Dr. Alanís has been the recipient of different academic and research awards and honors, and a number of licenses and certifications and has authored several scientific publications and chapters in peer-reviewed medical journals and medical books. He is an active member of numerous professional societies.
Dr. Alanís lives in Zionsville, Indiana with his wife Maria del Carmen and his four sons.